Use of Sacubitril/Valsartan in Chronic Heart Failure

Use of Sacubitril/Valsartan in Chronic Heart Failure

Impact of Sacubitril/Valsartan on Heart Failure  with concomitant Diabetes Mellitus

Impact of Sacubitril/Valsartan on Heart Failure with concomitant Diabetes Mellitus

Effect of Sacubitril-Valsartan in CKD End-stage

Effect of Sacubitril-Valsartan in CKD End-stage

Efficacy and Safety of Sacubitril/Valsartan

Efficacy and Safety of Sacubitril/Valsartan

Adoption of Sacubitril/Valsartan Heart Failure  Patients

Adoption of Sacubitril/Valsartan Heart Failure Patients

Requirement of Sacubitril/Valsartan and Loop Diuretic in Heart Failure

Requirement of Sacubitril/Valsartan and Loop Diuretic in Heart Failure

Sacubitril/Valsartan in Heart Failure

Sacubitril/Valsartan in Heart Failure

Pharmacological pillars at discharge after a  decompensation event

Pharmacological pillars at discharge after a decompensation event

Management of Heart Failure and Guidelines  Recommendation

Management of Heart Failure and Guidelines Recommendation

Safety and effectiveness of sodium–glucose cotransporter-2 inhibitors and angiotensin receptor-neprilysin inhibitor for patients with heart failure with reduced ejection fraction

Safety and effectiveness of sodium–glucose cotransporter-2 inhibitors and angiotensin receptor-neprilysin inhibitor for patients with heart failure with reduced ejection fraction